1997
DOI: 10.1038/sj.leu.2400662
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of immunoglobulin heavy chain gene rearrangement in patients with acute myelogenous leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
23
1

Year Published

2002
2002
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(28 citation statements)
references
References 3 publications
2
23
1
Order By: Relevance
“…The follow-up revealed that the complete remission rate and 2-year survival rate of the IgH rearrangement group were significantly lower than those of the negative IgH rearrangement group, indicating the IgH rearrangement may be a poor prognostic factor in AML, which was consistent with the results of Kyoda et al (1997). The significance of TCRγ rearrangement in AML has been little reported.…”
Section: Discussionsupporting
confidence: 79%
“…The follow-up revealed that the complete remission rate and 2-year survival rate of the IgH rearrangement group were significantly lower than those of the negative IgH rearrangement group, indicating the IgH rearrangement may be a poor prognostic factor in AML, which was consistent with the results of Kyoda et al (1997). The significance of TCRγ rearrangement in AML has been little reported.…”
Section: Discussionsupporting
confidence: 79%
“…This finding is not surprising because in one study, 40% (of 35 cases) of human AML also exhibit this type of rearrangement, as well as expressing some B-cell-specific antigens. 10 In this case series, the presence of an IgH rearrangement was associated with poorer survival. In another study, T-or B-cell receptor rearrangements were found in 2 of 16 patients with myelodysplastic syndrome that progressed to myelogenous leukemia.…”
Section: Discussionmentioning
confidence: 92%
“…The detection limits of the assay are similar to that reported in human patients. 10 Sensitivity can be increased at least 10-fold if primers specific for the individual tumor, rather than consensus primers, are used. 22 Although not practical for routine clinical use, this method is frequently used experimentally for the detection of minimum residual disease after chemotherapy in human patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…28 The former explanation is supported by the observation that histiocytic neoplasms occasionally arise in association with mediastinal germ-cell tumors 81,82 and that IgH rearrangements have been previously reported in myeloid sarcoma. 83,84 Alternatively, cross-contamination from positive cases or 'pseudomonoclonality' due to extremely low numbers of lymphocytes may contribute to false positive molecular testing results. 85,86 Although lymphocytes were sparse in the specimens in the present study, duplicate PCR testing decreases the likelihood of this pitfall.…”
Section: Discussionmentioning
confidence: 99%